BofA raised the firm’s price target on Arch Capital to $101 from $94 and keeps a Buy rating on the shares. Arch has announced that it intends to cancel several of the Bellemeade insurance-linked securities agreements spanning origination years 2018-2021, which should lift out-year EPS, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACGL: